ATAI — AtaiBeckley Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2081043 ·
Last close
$3.84
Market Cap
$1.41B
52W High
$5.51
52W Low
$3.27
ADV30
4,876,194
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 954,000 | — | -30,159,000 | -29,782,000 | 264,877,000 | 43,102,000 | 66,098,000 |
| Dec 2025 | 1,066,000 | — | -39,353,000 | -544,813,000 | 292,723,000 | 85,300,000 | 70,722,000 |
| Sep 2025 | 749,000 | — | -28,407,000 | -61,074,000 | 239,820,000 | 30,402,000 | 79,912,000 |
| Jun 2025 | 719,000 | — | -25,245,000 | -27,729,000 | 189,204,000 | 61,940,000 | 45,279,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-105,924,000
Investing CF
$-119,766,000
Financing CF
$210,697,000
CapEx
$-10,868,000
Dividends Paid
—
Buybacks
$-4,468,000
EPS Diluted TTM
$-2.23
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,390,036,000
Inventory
—
Receivables
$14,709,000
ST Investments
$187,665,000
EBIT TTM
$-663,060,000
Pretax Income TTM
$-663,322,000
Interest Exp TTM
$262,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,488,000
EBITDA
$-121,896,000
Free Cash Flow
$-55,528,624
Enterprise Value
$1,188,227,072
Total Cash
$230,767,008
Total Debt
$5,138,000
Shares Out
368,166,674
Trailing EPS
$-2.84
Book Value
$0.56
ROE
-378.0%
ROA
-33.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,089,000 | -113,347,000 | -660,047,000 | 292,723,000 | 70,722,000 | — | -102,675,000 |
| Dec 2024 | 308,000 | -102,166,000 | -149,269,000 | 159,387,000 | 42,833,000 | — | -82,437,000 |
| Dec 2023 | 314,000 | -123,026,000 | -40,224,000 | 293,478,000 | 49,162,000 | — | -84,118,000 |
| Dec 2022 | 233,000 | -144,430,000 | -152,385,000 | 305,441,000 | 39,675,000 | — | -104,467,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.46
Max Pain — expiry 2026-06-18
max pain strike: $4.00 · spot: $4.32 · call oi: 9,887 · put oi: 2,092
Expected Move to 2026-06-18:
±$0.40
(9.27%) —
implied range
$3.92 –
$4.72
· ATM straddle on $4.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | $1.41B | $19.19 | — |
| AVBP | ArriVent BioPharma, Inc. | $1.41B | $30.30 | — |
| BCAX | Bicara Therapeutics Inc. | $1.42B | $21.56 | — |
| ARDX | ARDELYX, INC. | $1.40B | $5.68 | — |
| GHRS | GH Research PLC | $1.40B | $20.37 | — |
News headlines (Yahoo Finance, 1h cache)
Wall Street Bullish on AtaiBeckley (ATAI), Here’s Why
2026-06-16 18:45 · Yahoo
Is AtaiBeckley Inc. (ATAI) the Hidden Penny Stock to Invest In?
2026-06-13 15:30 · Yahoo
Atai Beckley N.V. (ATAI) A Top Penny Stock to Buy Poised to Build Sustained Clinical and Shareholder Value
2026-06-07 17:57 · Yahoo
AtaiBeckley nears key clinical catalysts, Jefferies stays positive with repeat ‘Buy’ rating
2026-06-04 17:38 · Yahoo
Is AtaiBeckley’s BPL-003 Phase 3 Launch Altering The Investment Case For AtaiBeckley (ATAI)?
2026-06-04 06:11 · Yahoo
Assessing AtaiBeckley (ATAI) Valuation After Strong Returns And Elevated Price To Book Ratio
2026-06-04 02:12 · Yahoo
AtaiBeckley launches mental health patient impact grant program
2026-05-28 13:57 · Yahoo
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations
2026-05-28 13:00 · Yahoo
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
2026-05-27 10:00 · Yahoo
AtaiBeckley (ATAI) Reports Q1 Financial Results
2026-05-22 18:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.